Triazole fungicides induce hepatic lesions and metabolic disorders in rats

Mariam Jalal; Zakariya Nchioua; Said Chouham; Latifa Ez-Zaher

doi:10.30574/gscbps.2020.10.2.0002

Authors

Mariam Jalal Ibn Zohr University, Faculty of Science, Laboratory of Cell Biology and Molecular Genetics, Agadir, Morocco.
Zakariya Nchioua Ibn Zohr University, Faculty of Science, Laboratory of Cell Biology and Molecular Genetics, Agadir, Morocco.
Said Chouham Ibn Zohr University, Faculty of Science, Laboratory of Cell Biology and Molecular Genetics, Agadir, Morocco.
Latifa Ez-Zaher Ibn Zohr University, Faculty of Science, Laboratory of Cell Biology and Molecular Genetics, Agadir, Morocco.

DOI:

https://doi.org/10.30574/gscbps.2020.10.2.0002

Keywords:

Hexaconazole, Toxicity, Hepatic lesions, Metabolic disorders, Rat

Abstract

Pesticides are chemicals used in the treatment of agricultural products to increase production to meet growing consumer’s demand. Several studies have shown the toxic effects of these substances in humans as endocrine disrupters. The objective of our study is to highlight the toxic effects of hexaconazole in rats; a fungicide widely used in agriculture in Morocco. 16 rats received 100 mg/kg/day of hexaconazole orally via diet for 12 weeks. Biochemical analyses of the blood of treated animals showed a significant increase in creatinine, bilirubin, ASAT, ALAT and LDH levels, which would indicate toxicity in different organs. Also, a histological study of the liver was carried out. Microscopic observations showed several liver damages, such as centrilobular vein congestion, necrosis, immune cells infiltration, cholestasis, microvesicular and macrovesicular steatosis. These biochemical and histological results show that exposure to hexaconazole can cause liver and kidney damage. This pesticide would present an actual or potential danger to the consumer’s health.

Metrics

Metrics Loading ...

References

Rather IA, Koh WY, Paek WK and Lim J. (2017). The sources of chemical contaminants in food and their health implications. Frontiers in pharmacology, 8, 830.

Faostat FAO. (2016). Statistical databases. Food and Agriculture Organization of the United Nations.

Garcia FP, Ascencio SYC, Oyarzun JG, Hernandez AC and Alavarado PV. (2012). Pesticides: classification, uses and toxicity. Measures of exposure and genotoxic risks. J. Res. Environ. Sci. Toxicol, 1(11), 279-293.

Fenner K, Canonica S, Wackett LP and Elsner M. (2013). Evaluating pesticide degradation in the environment: blind spots and emerging opportunities. Science, 341(6147), 752-758.

Hester SD, Wolf DC, Nesnow S and Thai SF. (2006).Transcriptional profiles in liver from rats treated with tumorigenic and non-tumorigenic triazole conazole fungicides: propiconazole, triadimefon and myclobutanil. Toxicologic pathology, 34(7), 879-894.

Goetz AK and Dix DJ. (2009). Toxicogenomic effects common to triazole antifungals and conserved between rats and humans. Toxicology and applied pharmacology, 238(1), 80-89.

Poulsen R, Luong X, Hansen M, Styrishave B and Hayes T. (2015). Tebuconazole disrupts steroidogenesis in Xenopus laevis. Aquatic Toxicology, 168, 28-37.

Shen Z, Liu D, Wang P, Zhang P, Wang X and Zhou Z. (2013). Gender‐related in vitro metabolism of hexaconazole and its enantiomers in rats. Chirality, 25(12), 852-857.

Wang QX, Qiu J, Wang P, Jia GF, Wang P, Li JL and Zhou ZQ. (2005). Stereoselective kinetic study of hexaconazole enantiomers in the rabbit. Chirality: The Pharmacological, Biological, and Chemical Consequences of MolecularAsymmetry 17(4), 186-192.

Lee G and Goosens KA. (2015). Sampling blood from the lateral tail vein of the rat. JoVE (Journal of Visualized Experiments), (99), e52766.

Houlot R. (1984). Techniques d’histologie et de cytologie. Paris: Edition Maloine human disease: an overview. Methods Enzymol, 186, 1-85.

Prophet EB. (1992). Laboratory methods in histotechnology. American Registry of Pathology.

Bancroft JD and Gamble M. (2002). Theory and practice of histological techniques (5th ed). Churchill Livingstone. New York.

Institut national de l'environnement industriel et des risques, INERIS. (2011). Hexaconazole - CAS No. 79983-71-4, 1-21.

Kalakonda A and John S. (2019). Physiology, Bilirubin.

Amacher DE. (1998). Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regulatory toxicology and pharmacology, 27(2), 119-130.

Berridge BR, Van Vleet JF and Herman E. (2013). Cardiac, vascular, and skeletal muscle systems. In Haschek and Rousseaux's Handbook of Toxicologic Pathology, 1567-1665.

Goetz AK, Rockett JC, Ren H, Thillainadarajah I and Dix DJ. (2009). Inhibition of rat and human steroidogenesis by triazole antifungals. Systems biology in reproductive medicine, 55(5-6), 214-226.

Ekman DR, Keun HC, Eads CD, Furnish CM, Murrell RN, Rockett JC and Dix DJ. (2006). Metabolomic evaluation of rat liver and testis to characterize the toxicity of triazole fungicides. Metabolomics, 2(2), 63-73.

Wyss M and Kaddurah-Daouk R. (2000). Creatine and creatinine metabolism. Physiological reviews, 80(3), 1107-1213.

Peffer RC, Moggs JG, Pastoor T, Currie RA, Wright J, Milburn G and Rusyn I. (2007). Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor. Toxicological sciences, 99(1), 315-325.

Sun L, Li J, Zuo Z, Chen M and Wang C. (2013). Chronic exposure to paclobutrazol causes hepatic steatosis in male rockfish Sebastiscus marmoratus and the mechanism involved. Aquatic toxicology, 126, 148-153.

Konno Y, Negishi M and Kodama S. (2008). The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. Drug metabolism and pharmacokinetics, 23(1), 8-13.

Heikal TM, El-Sherbiny M, Hassan SA, Arafa A and Ghanem HZ. (2012). Antioxidant effect of selenium on hepatotoxicity induced by chlorpyrifos in male rats. Int J Pharm Sci, 4(4), 603-609.

Roelofs MJ, Temming AR, Piersma AH, van den Berg M and van Duursen MB. (2014). Conazole fungicides inhibit Leydig cell testosterone secretion and androgen receptor activation in vitro. Toxicology reports, 1, 271-283.

Strushkevich N, Usanov SA and Park HW. (2010). Structural basis of human CYP51 inhibition by antifungal azoles. Journal of molecular biology, 397(4), 1067-1078.

Mann DA and Smart DE. (2002). Transcriptional regulation of hepatic stellate cell activation. Gut, 50(6), 891-896.

Yang L, Chan CC, Kwon OS, Liu S, McGhee J, Stimpson SA and Rockey DC. (2006). Regulation of peroxisome proliferator-activated receptor-γ in liver fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 291(5), G902-G911.